Pursuit Wealth Management’s Gilead Sciences GILD Stock Holding History

Pursuit Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$715K	Buy	+5,826	New	+$708K	0.61%	57

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Pursuit Wealth Management's GILD Position: Q4 2025 in Review

Pursuit Wealth Management opened a new position in Gilead Sciences (GILD) in Q4 2025: 5,826 shares worth $715K. The stake represents 0.61% of the portfolio and ranks #57 among its holdings.

2,217 funds tracked by Wall St. Rank hold GILD as of Q4 2025.

Pursuit Wealth Management held 5,826 shares of Gilead Sciences worth $715K as of Q4 2025.
Gilead Sciences was a new Pursuit Wealth Management position in Q4 2025.
Gilead Sciences made up 0.61% of Pursuit Wealth Management's portfolio in Q4 2025, its #57 holding.
2,217 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2025.

Based on Pursuit Wealth Management's 13F filing for Q4 2025, filed 26 Jan 2026.